Skip to Main Content

Exclusive

Latest

Exclusive Megan Molteni

STAT Plus: How one scientist’s determination made Novo Nordisk an obesity-drug powerhouse

Exclusive Jonathan Wosen

STAT Plus: Failed biotech gives a rare peek inside the tough breaks — and tough choices — that led to its demise

Exclusive Rachel Cohrs and John Wilkerson

STAT Plus: Key Senate panel eyes action on drug shortages

Exclusive Mario Aguilar and Matthew Herper

STAT Plus: Biogen shutters digital health group, nixes Apple study, as part of cost cuts

Exclusive Lev Facher

Markey and Manchin urge FDA to stop its study of opioids for chronic pain

Exclusive Jason Mast

STAT Plus: David Liu startup to focus on getting CRISPR therapy to hard-to-reach cells

Exclusive Nicholas Florko

The food industry has tried to stack a key nutrition policy panel with its preferred experts, documents show

Exclusive Rachel Cohrs

STAT Plus: Eli Lilly CEO donates big to Mike Pence presidential super PAC

All Coverage

Exclusive John Wilkerson

STAT Plus: White House drug shortage task force held rare in-person meeting with industry

Exclusive Mario Aguilar

STAT Plus: Verily hires former Apple Health leader Andrew Trister as chief scientific officer

advertisement

Exclusive Sarah Owermohle

National panel will explore requiring free Covid tests

Exclusive Jonathan Wosen

STAT Plus: Truvian presents data for its desktop blood-testing device in a field still in Theranos’s shadow

Exclusive Mario Aguilar

STAT Plus: App developer Twill hunts for pharma partner to market its digital depression treatment

Exclusive Rachel Cohrs

STAT Plus: Key House panel plots a new health care package — complicating the chamber’s agenda

Exclusive Bob Herman

STAT Plus: Blue Cross Blue Shield plans in California evaded $170 million in taxes, whistleblower says

Exclusive John Wilkerson

STAT Plus: House panel expected to mark up pandemic-preparedness bill next week

Exclusive Rachel Cohrs

STAT Plus: Top federal lobbyist at PhRMA leaves

Exclusive Lev Facher

White House ‘naloxone summit’ omitting prominent advocates for lower costs

Exclusive Damian Garde and Adam Feuerstein

STAT Plus: Biotech executive nominated to Biogen board is mother of director’s child, records show

Exclusive Ellie Kincaid — Retraction Watch

STAT Plus: How a now-retracted study got published in the first place, leading to a $3.8 million NIH grant

Exclusive Rachel Cohrs

STAT Plus: Ted Love, BIO’s first Black board chair, aims to rehab biotech’s image in Washington

Exclusive Brittany Trang

STAT Plus: Hospitals want to buy doctors’ happiness with Nuance’s AI scribe. What they’re paying varies

Exclusive Usha Lee McFarling

‘A target on my back’: New survey shows racism is a huge problem in nursing

Exclusive Sarah Owermohle

STAT Plus: Sen. Elizabeth Warren probes abortion access amid states’ patchwork plans

Exclusive Rachel Cohrs

STAT Plus: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals

A STAT Investigation Nicholas Florko

‘Worse than what we thought’: New data reveals deeper problems with the Bureau of Prisons’ Covid response

Exclusive Lev Facher

STAT Plus: Biden drug czar: ‘All options are on the table’ for expanding methadone access

Exclusive Lev Facher

STAT Plus: Biden drug czar to summon naloxone makers to White House to discuss pricing

Exclusive Megan Molteni

From fusion to retooling cancer trials, Eric Lander wants his new group to ‘go after big problems’